DS
AMRI

DRW Securities’s Albany Molecular Research Inc AMRI Stock Holding History

DRW Securities’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-13,400
Closed -$291K – 96
2017
Q2 		$291K Buy
+13,400
New +$243K 0.05% 51

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

DRW Securities's AMRI Position: Q1 2015 in Review

DRW Securities sold out of Albany Molecular Research Inc (AMRI) in Q1 2015, closing a stake of 20,000 shares — an estimated $326K sold.

DRW Securities first reported a position in AMRI in Q2 2014 and held it in 2 quarters. The position peaked at $4.22M in Q2 2014. 131 funds tracked by Wall St. Rank hold AMRI as of Q1 2015.

  • DRW Securities reported no remaining Albany Molecular Research Inc position as of Q1 2015 after selling out during the quarter.
  • DRW Securities sold 20,000 Albany Molecular Research Inc shares in Q1 2015, an estimated $326K.
  • DRW Securities first reported a position in Albany Molecular Research Inc in Q2 2014 and held it in 2 quarters.
  • DRW Securities's Albany Molecular Research Inc position peaked at $4.22M in Q2 2014.
  • 131 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q1 2015.

Based on DRW Securities's 13F filing for Q1 2015, filed 15 May 2015.